source
- Takeda, Regeneron, Sanofi and Bristol Myers Squibb announce pipeline cuts in quarterly updatesTakeda, Regeneron, Sanofi and Bristol Myers Squibb disclosed that they are trimming several drug development programs as part of their recent earnings releases. The cuts affect a mix of early‑stage…
- Opinion: Ten years after WHO recognition, mycetoma remains one of the world’s most neglected diseases“The next 10 years of mycetoma care will determine whether it remains a story of neglect or becomes one of collective action,” writes Borna Nyaoke-Anoke.